Veracyte, Inc. announced that new data show the use of the Prosigna Breast Cancer Assay altered treatment decisions for patients with early-stage breast cancer,...
integrate.ai, a SaaS company helping organizations solve the world’s most important problems without risking the world’s most sensitive data, announced its central role in...
The Eureka Clinical AI platform, from ConcertAI's TeraRecon, now provides clinicians with the state-of-the-art artificial intelligence and deep learning technology necessary to automatically detect and segment...
Oncology Care Partners, an oncology provider built solely to provide value-based care, announces the launch of its first two practices across three locations, bringing...
Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, announced the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation...
